Learn more about a clinical trial examining a potential new treatment for depression in adult patients. Managing symptoms of depression can feel overwhelming, but you are not alone.
If you experience symptoms such as sadness, diminished interest or pleasure in things that you once enjoyed, appetite changes, sleep changes, fatigue, feelings of worthlessness or guilt, or thoughts of suicide or harming yourself, you may qualify for a clinical trial examining a new treatment option for depression. The Vitalize Clinical Study is evaluating a new type of investigational treatment for patients with depression that works differently than traditional antidepressants.
The study will include a total of 9 visits with the study doctor, over a period of 14 weeks. If you are qualified to participate, you will receive either the study drug, or placebo, as an oral tablet administered one time per week in the study clinic. As a study participant, you will also receive once-weekly evaluations of your depression and other symptoms, physical examinations and tests of your blood, urine, heart, and brain activity at no cost.
This study may be an option for you if you:
- are a healthy adult aged 18-64 with no other major illnesses
- have a diagnosis of depression
- are currently experiencing a major depressive episode that has lasted at least 3 weeks but no longer than 18 months
- are interested in trying a new treatment option, administered as an oral tablet once per week
- are interested in receiving thorough evaluations of your depression and health monitoring during your participation in the study
- are interested in contributing to the growing body of research about depression and new treatment options.
For more information on how to qualify for the Vitalize Clinical Study, please email